August 17, 2021
Because we believe in the best health for Canadians we have prepared a 10-point plan for the next federal government.
We believe:
- That the health of Canadians must be the number one priority of the next federal government.
- That a robust, responsive and high-quality healthcare system requires sustainable federal funding for health research and innovation.
- That the next federal government must engage in constructive dialogue with provinces and territories so that the mistakes of the past waves are not repeated in the looming fourth COVID wave.
- That the next federal government must urgently invest in Canada’s healthcare infrastructure to ensure the well-being of the population.
- That the next federal government must provide more support for mental health programs in Canada.
- That Canada’s older adult population deserves access to high-quality long-term and home care services.
- That the next federal government must build a national health human resource strategy to support the healthcare system strengthen health research and innovation in Canada.
- That the next federal government must undertake a comprehensive review of health transfers to provinces and territories to ensure equal access to high-quality healthcare services for all Canadians regardless of where they live.
- That the next federal government must urgently invest in health research
- That the next federal government ensures Canada is ready for the next pandemic by increasing public health spending and ensuring Canada’s self-sufficiency in pharmaceutical and vaccine production.
We believe in Canada’s future and that our nation can emerge from this pandemic stronger than ever. During this federal election campaign HealthCareCAN will work harder than ever with, and on behalf of, our member institutions dedicated to advancing the health of Canadians.
President & CEO, HealthCareCAN
HealthCareCAN is the national voice of healthcare organizations and hospitals across Canada. We foster informed and continuous, results-oriented discovery and innovation across the continuum of healthcare.
Related:
Canada is losing the race for clinical trials – and patients are paying the price
Oct. 8, 2026 Read article originally published in Healthy Debate By: Dr. Bettina Hamelin, President and CEO of Innovative Medicines Canada, and Michelle McLean, President and CEO of HealthCareCAN Canada has long punched above its weight in clinical trial activity: the rigorous, multi-stage research studies that give Canadians early access to breakthrough treatments. For years,
We’re Investing in AI for Healthcare. Now We Need the Infrastructure to Support It.
Oct. 5, 2026 Read article originally published in The Hill Times By: Michelle McLean It is no secret that the Canadian healthcare system faces unprecedented challenges – the strain of rising costs, an aging population with complex care needs, outdated and insufficient infrastructure, and a shortage of healthcare professionals. The challenges we face make it
Caring should never come with a threat
Oct. 1, 2026 Read article originally published in Hospital News By: Michelle McLean Bill S-233 would send an overdue message to Canada’s healthcare workers: violence is not part of the job. A healthcare worker’s shift should end when they leave the hospital. For some, the fear does not. As one HealthCareCAN member told us, healthcare
First order of business for Parliament: the protection of our healthcare workforce
Sept. 17, 2026 Read article originally published in The Hill Times By: Michelle McLean More than six years ago, people across Canada and in many countries around the world stepped outside onto their front steps, porches, and balconies to cheer and bang pots and pans for the healthcare workers on the frontlines of the COVID-19
Canada as Clinical Trials Powerhouse: A stretch goal within our grasp
April 22, 2026 Read article originally published in The Hill Times By: Michelle McLean Clinical trials, research studies that test new drugs, devices and procedures, are globally recognized as vital drivers of medical innovation, economic growth, and improved healthcare outcomes. Countries actively compete to attract these trials to foster strong healthcare research, provide citizens with early